Experience of the United Arab Emirates in the use of monoclonal antibody drug sotrovimab in high-risk vaccinated and unvaccinated patients with COVID-19: an observational cohort study

OBJECTIVES: Monoclonal antibodies can slow COVID-19 progression. This study describes the experience of using sotrovimab in patients with COVID-19 at high risk for disease progression and hospitalisation within the United Arab Emirates (UAE). DESIGN: Observational cohort study. SETTING: A tertiary h...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalateef, Sumaya, Al Meheiri, Noor Majed, Nassef, Mohamed, Shorrab, Ahmed A., Hashimi, Obaid Al Rahman, Allam, Samah, Alnaqbi, Mariam Saif, Al-Rifai, Rami H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835446/
https://www.ncbi.nlm.nih.gov/pubmed/36627160
http://dx.doi.org/10.1136/bmjopen-2022-066095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835446/
https://www.ncbi.nlm.nih.gov/pubmed/36627160
http://dx.doi.org/10.1136/bmjopen-2022-066095

Ejemplares similares